Mood stabilizers in the treatment of juvenile bipolar disorder - Advances and controversies

被引:0
作者
Davanzo, PA [1 ]
McCracken, JT [1 ]
机构
[1] Univ Calif Los Angeles, Inst Neuropsychiat, Div Child & Adolescent Psychiat, Dept Psychiat, Los Angeles, CA 90024 USA
关键词
D O I
暂无
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
This article summarizes the most recent clinical pharmacologic studies of mood stabilizers in children and adolescents with bipolar disorder. Based on these studies, a treatment algorithm is proposed. A brief review of the potential biologic predictors of treatment response in this population and of the newer anticonvulsants with mood stabilizing properties (e.g., lamotrigine, gabapentin, and topiramate) also is offered.
引用
收藏
页码:159 / +
页数:25
相关论文
共 50 条
[41]   The role of newer antiglutamatergic agents as mood-stabilizers in bipolar disorder [J].
Abelli, M ;
Martini, C ;
Pini, S ;
Gesi, C ;
Cassano, GB .
CURRENT DRUG TARGETS, 2005, 6 (05) :607-614
[42]   Childhood maltreatment and clinical response to mood stabilizers in patients with bipolar disorder [J].
Attianese, N. ;
Donato, S. ;
Battipaglia, M. ;
Ceres, R. ;
D'Agostino, G. ;
Cascino, G. .
EUROPEAN PSYCHIATRY, 2023, 66 :S575-S575
[43]   Mood stabilizers and the evolution of maintenance study designs in bipolar I disorder [J].
Calabrese, JR ;
Rapport, DJ .
JOURNAL OF CLINICAL PSYCHIATRY, 1999, 60 :5-13
[44]   Neuromolecular Etiology of Bipolar Disorder: Possible Therapeutic Targets of Mood Stabilizers [J].
Lee, Jung Goo ;
Woo, Young Sup ;
Park, Sung Woo ;
Seog, Dae-Hyun ;
Seo, Mi Kyoung ;
Bahk, Won-Myong .
CLINICAL PSYCHOPHARMACOLOGY AND NEUROSCIENCE, 2022, 20 (02) :228-239
[45]   Adverse drug reactions in the bipolar disorder patients treated with mood stabilizers [J].
Jankar, Bhausaheb Baliram ;
Gosavi, Devesh ;
Mishra, Kshirod Kumar ;
Sathe, Harshal Shriram .
ANNALS OF INDIAN PSYCHIATRY, 2024, 8 (01) :45-48
[46]   Long-term use of mood stabilizers in bipolar disorder - Introduction [J].
Bowden, CL .
JOURNAL OF CLINICAL PSYCHIATRY, 2002, 63 :3-4
[47]   Development of mood stabilizers based on mitochondrial dysfunction hypothesis of bipolar disorder [J].
Kato, T. .
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2014, 17 :5-5
[48]   Therapeutic drug monitoring of mood stabilizers in Medicaid patients with bipolar disorder [J].
Marcus, SC ;
Olfson, M ;
Pincus, HA ;
Zarin, DA ;
Kupfer, DJ .
AMERICAN JOURNAL OF PSYCHIATRY, 1999, 156 (07) :1014-1018
[49]   Mood Stabilizers, Oxidative Stress and Antioxidative Defense in Euthymia of Bipolar Disorder [J].
Bengesser, Susanne A. ;
Lackner, Nina ;
Birner, Armin ;
Platzer, Martina ;
Fellendorf, Frederike T. ;
Queissner, Robert ;
Filic, Kristijan ;
Reininghaus, Bernd ;
Wallner-Liebmann, Sandra J. ;
Mangge, Harald ;
Zelzer, Sieglinde ;
Fuchs, Dietmar ;
Kapfhammer, Hans-Peter ;
McIntyre, Roger S. ;
Reininghaus, Eva Z. .
CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS, 2016, 15 (04) :381-389
[50]   Childhood maltreatment and clinical response to mood stabilizers in patients with bipolar disorder [J].
Cascino, Giammarco ;
D'Agostino, Giulia ;
Monteleone, Alessio Maria ;
Marciello, Francesca ;
Caivano, Vito ;
Monteleone, Palmiero ;
Maj, Mario .
HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL, 2021, 36 (04)